ClearScreen

ClearScreen App – Regulatory Information Hub

ClearScreen App – Regulatory Information Hub

ClearScreen App – Regulatory Information Hub

1. About the ClearScreen app

The ClearScreen app is not itself a medical device. The ClearScreen app is not CE or UKCA marked. It is a launcher that gives healthcare professionals secure access to separate software medical devices, each of which reads a specific rapid test.

The app, published as ClearScreen Test Reader (Powered by TestCard), is for professional use by organisations that have a ClearScreen account. It provides the welcome and sign-in screens, user and patient ID entry, test selection, and any screens shown after a result is recorded. An organisation’s administrators manage users, locations and results through a separate web portal.

These launcher functions have no medical purpose. They do not meet the definition of an in vitro diagnostic medical device under Regulation (EU) 2017/746 (IVDR) or the UK Medical Devices Regulations 2002. The medical functions are provided only by the medical device modules listed in section 3.

2. How the medical device modules work

Each medical device module in the ClearScreen app is a separate software-only in vitro diagnostic medical device. Each medical device module is CE and UKCA marked in its own right, for professional use, with its own intended purpose, and TestCard Limited is the legal manufacturer of each medical device module.

Separate from the launcher. Each module provides its own test instructions, timings and result reading. The launcher does not pass data to a module, or between modules, or change how each module works.

Enabled per organisation. A user sees only the modules their organisation has enabled. Most organisations use one or a few of the modules listed in section 3.

Instructions are in the individual medical device modules. Each module has no packaging and no printed ‘traditional’ instructions for use. Its instructions for use are the step-by-step screens within the test flow detailed in each medical device module and the respective App Info screen, which shows TestCard Limited as the manufacturer, intended use, performance characteristics and symbols.

Labelling for each module. The public labelling for each module is linked in section 3.

3. Available medical device modules

The ClearScreen app hosts software medical device modules, each reading one manufacturer’s rapid test. All are for in vitro diagnostic use by healthcare professionals.

Device (trade name)

Test it reads (test manufacturer)

Detects

Regulatory status

UDI-DI

Labelling

CoreDx Combo Antigen Test Reader

CoreDx Influenza A/B + Covid-19/RSV Combo Ag Test Cassette (Core Tests)

SARS-CoV-2, influenza A and B, RSV antigens

CE and UKCA marked, professional use

(01)506069757CCARBF(8012)XXX(11)YYYYMMDD

Healgen COVID/Flu Reader

COVID-19/Flu A&B Ag Combo Rapid Test Cassette (Healgen Scientific LLC)

SARS-CoV-2, influenza A and B antigens

CE and UKCA marked, professional use

(01)50606975735005(8012)XXX(11)YYYYMMDD

Healgen One Step Pregnancy Reader

One Step Pregnancy Test Cassette (Healgen Scientific LLC)

hCG, as an indicator of pregnancy

CE and UKCA marked, professional use

(01)506069757HGPREK(8012)XXX(11)YYYYMMDD

Semi-quantitative PSA Reader

Various PSA LFDs, e.g., RightSign PSA Rapid Test Cassette (Whole Blood/Serum/Plasma) (Hangzhou Biotest Biotech Co., Ltd.)

PSA

CE and UKCA marked, professional use

(01)506069757PSARGS(8012)XXX(11)YYYYMMDD

SureScreen COVID Reader

COVID-19 Antigen Rapid Test (SureScreen Diagnostics)

SARS-CoV-2 antigen

CE and UKCA marked, professional use

(01)50606975732004(8012)XXX(11)YYYYMMDD

SureScreen COVID/Flu Reader

Dual Influenza/SARS-CoV-2 Antigen Test (SureScreen Diagnostics)

SARS-CoV-2, influenza A and B antigens

CE and UKCA marked, professional use

(01)50606975700522(8012)XXX(11)YYYYMMDD

SureScreen Pregnancy Reader

hCG Pregnancy Rapid Test Cassette (SureScreen Diagnostics)

hCG, as an indicator of pregnancy

CE and UKCA marked, professional use

(01)50606975733001(8012)XXX(11)YYYYMMDD

VISITECT CD4 Test Reader

VISITECT CD4 Advanced Disease Test (Accubio Limited)

CD4 cell count, as an indicator of advanced HIV disease

CE and UKCA marked, professional use

(01)506069757CD4RAG(8012)XXX(11)YYYYMMDD

Roche Combur10 UX Reader

Combur10 UX Urinalysis (Roche Diagnostics Ltd)

10 analytes urinalysis

CE and UKCA marked, professional use

(01)50606975730000(8012)XXX(11)YYYYMMDD

Modules are added to and retired from this list as the range changes. Your organisation’s ClearScreen administrator can tell you which modules are enabled for you.

4. Manufacturer and representatives

TestCard Limited is the legal manufacturer of the ClearScreen app and of every medical device module listed above.

Role

Name and address

Registration

Manufacturer

TestCard Limited, Unit 6, Betton Business Park, Racecourse Road, East Ayton, Scarborough, North Yorkshire, YO13 9HT, United Kingdom

EU SRN: GB-MF-000013002

MHRA registration: 10163

EU authorised representative

CS LifeSciences Europe Limited, The Black Church, St. Mary’s Place, Dublin 7, Dublin, D07 P4AX, Ireland

EU SRN: IE-AR-000004113

5. Support and reporting problems

For help with the app or a module, contact ClearScreen support at support@clearscreen.com.

Any serious incident that has occurred in relation to a device must be reported to the manufacturer and to the competent authority of the country where the user and/or patient is established:

  • United Kingdom: the MHRA, through the Yellow Card scheme.

  • EU/EEA: the competent authority of the Member State.

This page was last updated on 11 November 2026. Document Reference # DHF97-061, v1.0

ClearScreen Reader for clinical environments supports devices running Android 8+ and iOS 16+.

Copyright © 2024 ClearScreen ® by TestCard. All rights reserved.